These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30427563)

  • 41. Molecular diagnosis in patients with retinoblastoma: Report of a series of cases.
    Ossandón D; Zanolli M; López JP; Benavides F; Pérez V; Repetto GM
    Arch Soc Esp Oftalmol; 2016 Aug; 91(8):379-84. PubMed ID: 27021801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variability in retinoblastoma genome stability is driven by age and not heritability.
    Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
    Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma.
    Imperatore V; Pinto AM; Gelli E; Trevisson E; Morbidoni V; Frullanti E; Hadjistilianou T; De Francesco S; Toti P; Gusson E; Roversi G; Accogli A; Capra V; Mencarelli MA; Renieri A; Ariani F
    Eur J Hum Genet; 2018 Jul; 26(7):1026-1037. PubMed ID: 29662154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach.
    Samy MD; Yavorski JM; Mauro JA; Blanck G
    Cell Cycle; 2016 Jun; 15(12):1572-8. PubMed ID: 27074591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spectrum and tissue distribution of RB1 pathogenic alleles in mosaic retinoblastoma patients.
    Zhang Y; Wei WB; Zhao J; Xu X; Wang F
    Ophthalmic Genet; 2022 Dec; 43(6):795-805. PubMed ID: 35938543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A female patient with retinoblastoma and severe intellectual disability carrying an X;13 balanced translocation without rearrangement in the RB1 gene: a case report.
    Tsutsumi M; Hattori H; Akita N; Maeda N; Kubota T; Horibe K; Fujita N; Kawai M; Shinkai Y; Kato M; Kato T; Kawamura R; Suzuki F; Kurahashi H
    BMC Med Genomics; 2019 Dec; 12(1):182. PubMed ID: 31806026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prenatal genetic diagnosis of retinoblastoma and report of RB1 gene mutation from India.
    Shah PK; Sripriya S; Narendran V; Pandian AJ
    Ophthalmic Genet; 2016 Dec; 37(4):430-433. PubMed ID: 26914665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of anthracycline-based chemotherapy on RB1 gene methylation in peripheral blood leukocytes and biomarkers of oxidative stress and inflammation in sarcoma patients.
    Pokupec Bilić A; Bilić I; Radić Brkanac S; Simetić L; Blažičević K; Herceg D; Mikloš M; Tonković Đurišević I; Domijan AM
    Clin Transl Oncol; 2024 Jun; 26(6):1508-1518. PubMed ID: 38310203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide methylation analysis of retrocopy-associated CpG islands and their genomic environment.
    Grothaus K; Kanber D; Gellhaus A; Mikat B; Kolarova J; Siebert R; Wieczorek D; Horsthemke B
    Epigenetics; 2016 Mar; 11(3):216-26. PubMed ID: 26890210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC.
    Morak M; Schackert HK; Rahner N; Betz B; Ebert M; Walldorf C; Royer-Pokora B; Schulmann K; von Knebel-Doeberitz M; Dietmaier W; Keller G; Kerker B; Leitner G; Holinski-Feder E
    Eur J Hum Genet; 2008 Jul; 16(7):804-11. PubMed ID: 18301449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [RB1 and CDKN2A functional defects resulting in retinoblastoma].
    Babenko OV; Zemliakova VV; Saakian SV; Brovkina AF; Strel'nikov VV; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2002; 36(5):777-83. PubMed ID: 12391839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma.
    Indovina P; Acquaviva A; De Falco G; Rizzo V; Onnis A; Luzzi A; Giorgi F; Hadjistilianou T; Toti P; Tomei V; Pentimalli F; Carugi A; Giordano A
    J Cell Physiol; 2010 Apr; 223(1):143-50. PubMed ID: 20039270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications.
    Gregersen PA; Urbak SF; Funding M; Overgaard J; Jensen UB; Alsner J
    Acta Oncol; 2016; 55(4):412-7. PubMed ID: 26494512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma.
    Sun S; Wang R; Yi S; Li S; Wang L; Wang J
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma.
    Ohtani-Fujita N; Dryja TP; Rapaport JM; Fujita T; Matsumura S; Ozasa K; Watanabe Y; Hayashi K; Maeda K; Kinoshita S; Matsumura T; Ohnishi Y; Hotta Y; Takahashi R; Kato MV; Ishizaki K; Sasaki MS; Horsthemke B; Minoda K; Sakai T
    Cancer Genet Cytogenet; 1997 Oct; 98(1):43-9. PubMed ID: 9309117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mosaicism and prenatal diagnosis options: insights from retinoblastoma.
    Dehainault C; Golmard L; Millot GA; Charpin A; Laugé A; Tarabeux J; Aerts I; Cassoux N; Stoppa-Lyonnet D; Gauthier-Villars M; Houdayer C
    Eur J Hum Genet; 2017 Feb; 25(3):381-383. PubMed ID: 28000698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers.
    Le Gall J; Dehainault C; Benoist C; Matet A; Lumbroso-Le Rouic L; Aerts I; Jiménez I; Schleiermacher G; Houdayer C; Radvanyi F; Frouin E; Renault V; Doz F; Stoppa-Lyonnet D; Gauthier-Villars M; Cassoux N; Golmard L
    J Mol Diagn; 2021 Dec; 23(12):1714-1721. PubMed ID: 34656762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
    Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
    Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
    [No Abstract]   [Full Text] [Related]  

  • 60. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.
    Kooi IE; Mol BM; Massink MP; Ameziane N; Meijers-Heijboer H; Dommering CJ; van Mil SE; de Vries Y; van der Hout AH; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
    Sci Rep; 2016 Apr; 6():25264. PubMed ID: 27126562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.